A company still losing money with steady sales.
Facts from SEC filings, not a recommendation.
From SG's last IEX trade and its SEC filings (profits and sales over the last four quarters). A starting point for research, not a verdict.
Last 12 months: $681.8M, down 0.6% from the 12 months before. Over 5 years, sales grew about 25% a year.
Move the sliders to your own view of SG. Starting points are the company's recent numbers.
What today's price needs: with a 2% margin and a 40x P/E, sales would have to grow about 14% a year for 5 years just to match today's price.
Simple math on your guesses, not a forecast or a price target. Real results depend on many things these sliders leave out.
Price chart by TradingView.
From annual reports filed with the SEC. Not in this company's SEC data, so not scored: debt under half of equity, gross margin 40%+. A checklist is a starting point for research, not a verdict.
No open-market insider buys or sells in the last 90 days.
No trades to chart yet.
SEC filings of any kind. 50 means a normal week.
Institutions added 0.8% to their holdings. 128 bought, 87 sold. 2 quarters of net buying in a row.
No open-market buys or sells in 90 days. Grants and option exercises are left out.
"Owns after" is the insider's holding right after the trade. Pre-planned (10b5-1) sales are set up months ahead, a weaker signal.
15,038 shares at $7.99 · $120K
4,809 shares at $6.21 · $30K
1,401 shares at $8.00 · $11K
15,033 shares at $6.21 · $93K
Source: SEC EDGAR filings. For informational purposes. Not investment advice.
Report a problem with this page